No open-market selling at Cascade Private Capital Fund in the past year, which is unusual. Instead two corporate insiders bought about $1.2 million worth of CPEFX.
Garcia Dominic Jerome (Director) made the biggest buy, worth around $548,000.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 4 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Garcia Dominic Jerome | Director | Buy | 9,203 | $20.91 | $192K | SEC |
| Mar 26, 2026 | Worley Matthew Eugene | Director | Buy | 24,486 | $20.42 | $500K | SEC |
| Mar 6, 2026 | Garcia Dominic Jerome | Director | Buy | 26,775 | $20.46 | $548K | SEC |
| Jul 14, 2025 | Nesbitt Stephen Lane | President | Buy | 52,687 | $18.98 | $1.0M | SEC |
| Jan 27, 2025 | Williams Paul Jay | Director | Buy | 9,324 | $17.16 | $160K | SEC |
| Jul 22, 2024 | Williams Paul Jay | Director | Buy | 3,759 | $15.96 | $60K | SEC |
| Mar 25, 2024 | Williams Paul Jay | Director | Buy | 12,409 | $13.70 | $170K | SEC |
| Mar 25, 2024 | Williams Paul Jay | Director | Buy | 3,360 | $13.69 | $46K | SEC |
In the last 12 months Cascade Private Capital Fund insiders made open-market purchases worth about $1.2 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CPEFX was filed on 2026-04-16.
No congressional trades in CPEFX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).